Indigo

medical devices

About

Indigo is a Belgian medical device company focused on developing the world's first continuous multi-metabolite monitoring (CMM®) system for individuals with chronic diseases, particularly diabetes. Founded in 2016 as a spin-off from Ghent University and imec, Indigo is headquartered in Ghent, Belgium, with a subsidiary in Boston, USA. The company's core product is a small, subcutaneously implanted sensor that utilizes silicon photonics technology to measure multiple metabolites, including glucose, ketones, and lactate, in real time. This discreet sensor can remain implanted for up to two years and transmits data wirelessly to a mobile app, allowing users and caregivers to monitor trends and values easily. Indigo's CMM system aims to enhance the management of chronic diseases and has potential applications in areas such as chronic kidney disease, oncology, and cardiovascular health. The company is led by experienced professionals in the field, including Dr. Danaë Delbeke and CEO Peter J. Devlin.

Technologies

Outlook WordPress.org Google Tag Manager Apache Mobile Friendly Google Font API reCAPTCHA

Keywords

medical equipment manufacturing clinical feasibility studies implantable sensor healthcare equipment & supplies silicon photonics technology real-time data chronic disease management non-invasive technology spectral data collection metabolic health patient data sharing clinical investigation biomarker sensing regulatory compliance discreet health monitoring wireless connectivity bluetooth connectivity b2b spectroscopy in healthcare miniaturized sensors continuous multi-metabolite monitoring metabolite sensing healthcare technology silicon photonics spectral absorption measurement multi-metabolite sensor applications medical devices multi-analyte health monitoring nanophotonics interstitial fluid analysis

Location

2B Bollebergen, Ghent, Flanders, Belgium, 9052

Related Companies

Companies in the same industry